MENU
INM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
InMed Pharmaceuticals (INM) Ownership - Who owns InMed Pharmaceuticals?
Profile
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
3.73M
P/E Ratio
0.02
Total Cash
5.58M
Projected Growth
N/A
Total Debt
1.06M
Revenue
4.96M
Risk (Beta)
0.36
Dividend Yield
N/A
Total Cash/Share
7.77
Total Debt/Equity
N/A
Revenue/Share
12.83 USD as % of share price
Fundamentals
INM
Capitalization
3.73M
P/E Ratio
0.02
Risk (Beta)
0.36
Dividend Yield
N/A
Total Cash
5.58M
Total Cash/Share
7.77
Total Debt
1.06M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
12.83%
Revenue
4.96M
ROE
N/A
Book Value
8.4M
P/B Ratio
0.44
Cash Flow
N/A
Earnings
230.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
84.2M
Current Ratio
5.07
Current Revenue Per Employee
95400.00
Dividends Per Share - Security
N/A
EBITDA
-6.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
39.02
Revenue To Assets
-63.76
Shares Held By Institutions
349K
Shares Outstanding - Current
718K
Total Liabilities
2.07M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-37.620
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com